Björn Hegemann is a strategic and innovative leader in research and development, with extensive experience in drug discovery and process development. They served as a Visiting Scientist for Proteomics at CSL in 2020, and prior to that, held various roles at CSL Behring from 2016 to 2020, including Associate Director and Senior Scientist. Björn completed a Postdoctoral Fellowship at the Research Institute of Molecular Pathology between 2008 and 2009, and attained a PhD from Universität Wien in 2008 after earning a Diploma in Biochemistry from Universität Potsdam in 2004. Their expertise includes immunology, rare diseases, and cross-functional collaboration.
This person is not in any teams
This person is not in any offices